International Journal of Neuroscience · 2011 · 51 citations · 27 references
MedicineNeurosciencePharmacologyMolecular NeurobiologyMolecular NeuroscienceNeuropharmacologyDopaminergic PharmacologyNeurodegeneration MechanismsNeurodegenerative DiseasesNeuroprotectionParkinson DiseaseParkinsonian DisordersDopaminergic Neuron DeathDopaminergic NeuroprotectionDopaminergic PathwaysIntranasal AdministrationParkinsonian DegenerationParkinsonian NeuroprotectionParkinson’s Disease PharmacotherapyParkinson’s Disease Treatment
It has been reported that acupuncture treatment reduced dopaminergic neuron degeneration in Parkinson's disease (PD) models. However, the mechanistic pathways underlying, such neuroprotection, are poorly understood. Here, we investigated the effects and the underlying mechanism of acupuncture in a mouse model of PD using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). First, we observed that MPTP-induced impairment of Akt activation, but not MPTP-induced c-Jun activation, was effectively restored by acupuncture treatment in the substantia nigra. Furthermore, we demonstrated for the first time that the brain-specific blockade of phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway, by intranasal administration of LY294002, a specific inhibitor of PI3K/Akt signaling pathway, significantly blocked acupuncture-induced dopaminergic neuron protection and motor function improvement. Our results provide evidence that PI3K/Akt signaling pathway may play a central role in the mechanism underlying acupuncture-induced benefits in Parkinsonian mice.
27
Yufeng Yang, Stephan Gehrke, Md. Emdadul Haque et al. · Proceedings of the National Academy of Sciences · 2005 · 341 citations · Full text
Giselle M. Petzinger, John Walsh, Garnik Akopian et al. · Journal of Neuroscience · 2007 · 327 citations · Full text
Roberta De Rosa, Addys Ancheta Garcia, Chiara Braschi et al. · Proceedings of the National Academy of Sciences · 2005 · 303 citations · Full text